VERTEX PHARMACEUTICALS INC / MA Restructuring Reserve
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Restructuring Reserve of $22.46 million as of 2013-03-31, per its 10-Q filed 2013-05-08.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2015-02-13
- 2013-03-31: Restructuring Reserve $22.46M.
- 2012-12-31: Restructuring Reserve $22.46M; Restructuring Reserve as first filed $23.33M.
- 2012-09-30: Restructuring Reserve $24.16M.
- 2012-06-30: Restructuring Reserve $24.83M.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2013-03-31 | $22.46M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $22.46M 10-Q · filed 2013-08-02 | $23.33M 10-K · filed 2013-03-01 |
| 2012-09-30 | $24.16M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $24.83M 10-Q · filed 2012-11-06 | |
| 2012-03-31 | $24.83M 10-Q · filed 2013-08-02 | $25.47M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $25.47M 10-Q · filed 2013-08-02 | $26.31M 10-K · filed 2012-02-22 |
| 2011-09-30 | $26.58M 10-Q · filed 2012-11-06 | |
| 2011-06-30 | $28.20M 10-Q · filed 2012-11-06 | |
| 2011-03-31 | $28.81M 10-Q · filed 2012-08-08 | |
| 2010-12-31 | $29.59M 10-K · filed 2013-03-01 | |
| 2010-09-30 | $33.24M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $33.92M 10-Q · filed 2011-11-03 | |
| 2010-03-31 | $33.33M 10-Q · filed 2011-08-09 | |
| 2009-12-31 | $34.02M 10-K · filed 2013-03-01 | |
| 2009-09-30 | $33.36M 10-Q · filed 2010-10-28 | |
| 2009-06-30 | $34.05M 10-Q · filed 2010-10-28 | |
| 2009-03-31 | $34.81M 10-Q · filed 2010-08-03 | |
| 2008-12-31 | $34.06M 10-K · filed 2012-02-22 | |
| 2007-12-31 | $35.29M 10-K · filed 2011-02-17 | |
| 2003-12-31 | $69.53M 10-K · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |